{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:24:56Z","timestamp":1771064696211,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10549-018-05114-7","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T05:53:11Z","timestamp":1546408391000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-4742","authenticated-orcid":false,"given":"Pierre","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alwin","family":"Jeyakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tallal","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"5114_CR1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.71.4147","author":"JL Blum","year":"2016","unstructured":"Blum JL, Flynn PJ, Yothers G, Asmar L, GeyerJr CE, Jacobs SA, Robert NJ, Hopkins JO, O\u2019Shaughnessy JA, Dang CT, G\u00f3mez HL, Fehrenbacher L, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Jeong J-H, Colangelo LH, Swain SM, Mamounas EP, Jones SE, Wolmark N (2016) Anthracyclines in early breast cancer: the ABC trials\u2014USOR 06\u2013090, NSABP B-46-I\/USOR 07132, and NSABP B-49 (NRG oncology). J Clin Oncol. \n                    https:\/\/doi.org\/10.1200\/jco.2016.71.4147","journal-title":"J Clin Oncol"},{"issue":"11","key":"5114_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S1470-2045(05)70424-1","volume":"6","author":"M Trudeau","year":"2005","unstructured":"Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S (2005) Selection of adjuvant chemotherapy for treatment of node-positive breast cancer. Lancet Oncol 6(11):886\u2013898. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(05)70424-1","journal-title":"Lancet Oncol"},{"issue":"9472","key":"5114_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(05)66544-0","journal-title":"Lancet"},{"issue":"11","key":"5114_CR4","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"SM Swain","year":"2003","unstructured":"Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97(11):2869\u20132879. \n                    https:\/\/doi.org\/10.1002\/cncr.11407","journal-title":"Cancer"},{"issue":"17","key":"5114_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","volume":"104","author":"EJ Bowles","year":"2012","unstructured":"Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 104(17):1293\u20131305. \n                    https:\/\/doi.org\/10.1093\/jnci\/djs317","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5114_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12094-016-1508-y","volume":"19","author":"J Gavila","year":"2017","unstructured":"Gavila J, Segu\u00ed M, Calvo L, L\u00f3pez T, Alonso JJ, Farto M, S\u00e1nchez-de la Rosa R (2017) Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study. Clin Transl Oncol 19(1):91\u2013104. \n                    https:\/\/doi.org\/10.1007\/s12094-016-1508-y","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"5114_CR7","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/1097-0142(197704)39:4<1397::AID-CNCR2820390407>3.0.CO;2-U","volume":"39","author":"RA Minow","year":"1977","unstructured":"Minow RA, Benjamin RS, Lee ET, Gottlieb JA (1977) Adriamycin cardiomyopathy\u2013risk factors. Cancer 39(4):1397\u20131402","journal-title":"Cancer"},{"issue":"9","key":"5114_CR8","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/01.CIR.0000073597.57414.A9","volume":"108","author":"MD Cheitlin","year":"2003","unstructured":"Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO (2003) ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (ACC\/AHA\/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). Circulation 108(9):1146\u20131162. \n                    https:\/\/doi.org\/10.1161\/01.cir.0000073597.57414.a9","journal-title":"Circulation"},{"issue":"SUPPL. 7","key":"5114_CR9","doi-asserted-by":"publisher","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T, Plataniotis G, De azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol 23(SUPPL. 7):vii155\u2013vii166. \n                    https:\/\/doi.org\/10.1093\/annonc\/mds293","journal-title":"Ann Oncol"},{"issue":"8","key":"5114_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 35(8):893\u2013911. \n                    https:\/\/doi.org\/10.1200\/jco.2016.70.5400","journal-title":"J Clin Oncol"},{"key":"5114_CR11","unstructured":"Higgings JPTGS (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). \n                    http:\/\/handbook.cochrane.org"},{"issue":"4","key":"5114_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00000421-200108000-00027","volume":"24","author":"MS Sabel","year":"2001","unstructured":"Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB (2001) Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Am J Clin Oncol 24(4):425\u2013428. \n                    https:\/\/doi.org\/10.1097\/00000421-200108000-00027","journal-title":"Am J Clin Oncol"},{"key":"5114_CR13","first-page":"S208","volume":"88","author":"P McIlroy","year":"2004","unstructured":"McIlroy P, Khorrami J, Mohanlal P, Canney P, Stirling L, MacKay H, Reid S (2004) MUGA scan pre-anthracycline adjuvant chemotherapy for breast cancer - worthwhile or worthless? Breast Cancer Res Treat 88:S208\u2013S208","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5114_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clbc.2011.07.006","volume":"12","author":"A Jeyakumar","year":"2012","unstructured":"Jeyakumar A, Dipenta J, Snow S, Rayson D, Thompson K, Theriault C, Younis T (2012) Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy. Clin Breast Cancer 12(1):4\u20139. \n                    https:\/\/doi.org\/10.1016\/j.clbc.2011.07.006","journal-title":"Clin Breast Cancer"},{"key":"5114_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-014-1004-0","author":"A Mina","year":"2015","unstructured":"Mina A, Rafei H, Khalil M, Hassoun Y, Nasser Z, Tfayli A (2015) Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients. BMC Cancer. \n                    https:\/\/doi.org\/10.1186\/s12885-014-1004-0","journal-title":"BMC Cancer"},{"issue":"6","key":"5114_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1634\/theoncologist.2015-0449","volume":"21","author":"SR Truong","year":"2016","unstructured":"Truong SR, Barry WT, Moslehi JJ, Baker EL, Mayer EL, Partridge AH (2016) Evaluating the utility of baseline cardiac function screening in early-stage breast cancer treatment. Oncologist 21(6):666\u2013670. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0449","journal-title":"Oncologist"},{"issue":"4","key":"5114_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4048\/jbc.2016.19.4.402","volume":"19","author":"HJ Yoon","year":"2016","unstructured":"Yoon HJ, Kim KH, Kim JY, Park HJ, Cho JY, Hong YJ, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC (2016) Chemotherapy-induced left ventricular dysfunction in patients with breast cancer. J Breast Cancer 19(4):402\u2013409. \n                    https:\/\/doi.org\/10.4048\/jbc.2016.19.4.402","journal-title":"J Breast Cancer"},{"key":"5114_CR18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.SABCS13-P6-06-09","author":"MM Abu-Khalaf","year":"2013","unstructured":"Abu-Khalaf MM, Medic I, Hatzis C, Park E, Chung G, DiGiovanna M, Hofstatter E, Sanft T, Pusztai L, Gross C, Russell K, Russell R (2013) Baseline assessment of left ventricular function for breast cancer patients undergoing anthracycline and\/or trastuzumab: What is the prevalence of baseline dysfunction? Can Res. \n                    https:\/\/doi.org\/10.1158\/0008-5472.SABCS13-P6-06-09","journal-title":"Can Res"},{"key":"5114_CR19","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1200\/JCO.2016.34.15_suppl.6608","volume":"34","author":"P Peddi","year":"2016","unstructured":"Peddi P, Master SR, Ravipati HP, Patel AH, Dwary AD, Pasam A, Chu Q, Shi R, Von Burton G (2016) Pre-treatment evaluation of LVEF for breast cancer patients receiving anthracyclines: is it necessary? J Clin Oncol 34:6608","journal-title":"J Clin Oncol"},{"issue":"3","key":"5114_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ehjci\/jet159","volume":"15","author":"K Negishi","year":"2014","unstructured":"Negishi K, Negishi T, Haluska BA, Hare JL, Plana JC, Marwick TH (2014) Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15(3):324\u2013331. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jet159","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"5114_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cjca.2016.02.078","volume":"32","author":"SA Virani","year":"2016","unstructured":"Virani SA, Dent S, Brezden-Masley C, Clarke B, Davis MK, Jassal DS, Johnson C, Lemieux J, Paterson I, Sebag IA, Simmons C, Sulpher J, Thain K, Thavendiranathan P, Wentzell JR, Wurtele N, Cote MA, Fine NM, Haddad H, Hayley BD, Hopkins S, Joy AA, Rayson D, Stadnick E, Straatman L (2016) Canadian cardiovascular society guidelines for evaluation and management of cardiovascular complications of cancer therapy. Can J Cardiol 32(7):831\u2013841. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2016.02.078","journal-title":"Can J Cardiol"},{"issue":"Suppl 1 Special","key":"5114_CR22","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.2459\/JCM.0000000000000381","volume":"17","author":"P Spallarossa","year":"2016","unstructured":"Spallarossa P, Maurea N, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G (2016) A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown, Md) 17(Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection):e84\u2013e92. \n                    https:\/\/doi.org\/10.2459\/jcm.0000000000000381","journal-title":"J Cardiovasc Med (Hagerstown, Md)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-05114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-05114-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-05114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T19:07:42Z","timestamp":1577905662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-05114-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["5114"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-05114-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}}]}}